Eating Disorders (EDs) Market Insight Business Opportunities, Revenue, Gross Margin and Forecast to 2029

The eating disorder market is expected to witness market growth at a rate of 5.8% in the forecast period of 2022 to 2029. Data Bridge Market Research report on eating disorder market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in healthcare sector globally is escalating the growth of eating disorder market.
Eating disorder refers to a complex mental health condition that usually requires psychiatric and medical assistance. A common misconception exists regarding eating habits such as overeating eating is healthy lifestyle choice. The disorder might develop with obsession with food, body weight and size that leads to some serious health problems including diabetes, cardiovascular diseases, anxiety, and depression, among others.

Asceses Full report@- https://www.databridgemarketresearch.com/reports/global-eating-disorders-eds-market

Global eating disorder market is segmented on the basis of type, treatment, patients, route of administration, end-users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
• On the basis of type, the eating disorder market is segmented into anorexia nervosa, bulimia nervosa, binge eating disorder, pica, rumination disorder, avoidant/restrictive food intake disorder, purging disorder, night eating syndrome and others.
• On the basis of treatment, the eating disorder market is segmented into medications, therapies and others. Treatment by medication is further segmented into antidepressants, antipsychotics, mood stabilizers and others. Therapies is further segmented into cognitive behavioural therapy, family-based therapy and other.
• On the basis of patients, the eating disorder market is segmented into inpatients and outpatients.
• On the basis of route of administration, the eating disorder market is segmented into oral, parenteral, topical and others.
• On the basis of end-users, the eating disorder market is segmented into hospitals, specialty clinics and others.
• On the basis of distribution channel, the eating disorder market has also been segmented into hospital pharmacy, retail pharmacy and others.

Related Report@-
https://databridgeshilp.blogspot.com/2023/12/hyperbaric-oxygen-therapy-hbot-market.html
https://databridgeshilp.blogspot.com/2023/12/maternal-health-market-insight-business.html
https://databridgeshilp.blogspot.com/2023/12/ultrasound-probe-disinfection-market.html
https://databridgeshilp.blogspot.com/2023/12/cath-lab-services-market-growth_18.html

Some of the major players operating in the eating disorder market are Bausch & Lomb Incorporated, Apotex Inc., Somerset Therapeutics, LLC, Mylan N.V., Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceutical LLC., Eli Lilly and Company. AbbVie Inc., and GlaxoSmithKline Plc among others.

Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.